Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services

Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the Centers for Medicare & Medicaid Services has designated the Nodify...

Related Keywords

Scott Hutton ,Laboratory Test ,Biodesix Inc ,Centers For Medicare Medicaid Services ,Nasdaq ,Medicaid Services ,Advanced Diagnostic Laboratory Test ,Protecting Access ,Medicare Act ,Medicare Administrative Contractor ,Nodule Risk Assessment ,Artificial Intelligence ,Private Securities Litigation Reform Act ,Risk Factors ,